Multiple Myeloma is a type of bone marrow cancer that develops from plasma cells responsible for producing antibodies essential for the immune system.
When these cells become cancerous, they multiply uncontrollably, replacing normal cells and affecting blood production.
Symptoms of Multiple Myeloma can vary but commonly include:
Painful sensation in the bones, especially in the spine or chest area
Nausea
Constipation problems
Loss of appetite
Disorientation or mental confusion
Constant feeling of fatigue
Frequent episodes of infections
Weight loss
Feeling of weakness or numbness in the legs
Significant increase in thirst
Multiple Myeloma presents various characteristics that affect multiple body systems, causing notable complications.
The excessive proliferation of plasma cells in the bone marrow can displace normal blood cells, resulting in low counts.
This leads to anemia, causing weakness and fatigue.
It can cause thrombocytopenia, reducing platelets and increasing the risk of bleeding and bruising.
Leukopenia, a shortage of white blood cells, can weaken the body's ability to fight infections.
Myeloma cells weaken the bones by interfering with the balance between osteoclasts and osteoblasts.
Increases bone degeneration, increasing fragility and the risk of fractures.
Releasing substances by myeloma cells can raise calcium levels in the blood, with detrimental health consequences.
The proliferation of abnormal plasma cells displaces normal plasma cells, affecting antibody production.
The lack of efficient antibodies leaves the body vulnerable to infections, as myeloma cells cannot effectively fight germs.
Myeloma cells produce an antibody that can damage the kidneys, leading to kidney damage and potential renal failure.
Early attention from specialists in Hematology and Oncology is crucial to offering an appropriate approach and improving patients' quality of life.
Although the exact cause of Multiple Myeloma is not fully understood, there are risk factors that can increase the likelihood of developing this disease. The likelihood of developing Multiple Myeloma is influenced by various factors, including:
Advanced Age: Most cases are diagnosed in individuals over 65.
Male Gender: Men are more prone to manifest this disease compared to women.
Race: People of African descent have a higher predisposition to develop Multiple Myeloma compared to individuals of other races.
Family History: Having direct relatives, such as siblings, sisters, or parents, with a history of Multiple Myeloma increases the individual risk of contracting the disease.
Personal History of MGUS (Monoclonal Gammopathy of Undetermined Significance): Since Multiple Myeloma generally originates from MGUS, having this prior condition increases the probability of developing the disease.
It is also important to mention that, almost always, Multiple Myeloma begins as a relatively benign disease called "monoclonal gammopathy of undetermined significance."
Monoclonal gammopathy of undetermined significance, like Multiple Myeloma, is characterized by M proteins in the blood (produced by abnormal plasma cells). However, in monoclonal gammopathy of undetermined significance, M protein levels are lower, and the body does not suffer damage.
The diagnosis of Multiple Myeloma involves laboratory tests, imaging, and bone marrow biopsies. It is crucial to have specialists intervene to determine the most appropriate treatment plan.
In the early stages, Hematologists are key to managing the disease, while in advanced phases, Oncologists become the fundamental specialists of the medical team.
If you experience symptoms such as persistent bone pain, extreme fatigue, or recurrent problems, it is necessary to consult a Hematologist or an Oncologist. Early detection of Multiple Myeloma can significantly improve treatment options and the patient's quality of life.
In the search for the best medical care, BlueNetHospitals is your best option. Contact us, and our team of Hematology and Oncology will guide and support you at all times.
BlueNetHospitals
BlueNet Hospitals - Blue Net Hospitals
Non-Hodgkin's lymphomas are a type of cancer that impacts the lymphatic system.
Leukemia cannot be completely prevented, but there are measures that can be taken to reduce the risk of developing it.
Anemia often results in a weak condition and a feeling of tiredness. Anemia is characterized by an abnormally low number of healthy red blood cells in the blood. Red blood cells that carry oxygen around in your organism.